Cerebras Systems is down 20% this year, and one respected Wall Street analyst says the stock is set to double in price.

Cerebras lost more than half its value from its first-day close, insiders cashed out hundreds of millions, and then OpenAI handed a marquee speed workload to a rival. One top Wall Street analyst still raised his target.

Cerebras Systems (NASDAQ:CBRS) currently trades at $146.62. The average analyst price target is $291.64, which implies about 98.9% upside.

Cerebras makes wafer-scale AI chips and leases that compute through its own inference cloud. Its pitch is speed, as an alternative to GPUs. Wall Street has paid attention because of contracted demand: $25.4B in remaining performance obligations, backed by a multi-year OpenAI deal for 750 MW of inference compute.

A gap this wide at a company that just raised full-year guidance means one side is badly wrong. Either analysts are slow to react, or the market is overreacting to a handful of headlines.

**OpenAI Hands a Speed Workload to NVIDIA, and Cerebras Sinks Below Its IPO Price**

The biggest blow came from a SemiAnalysis report that OpenAI will power the "Ultrafast" mode for GPT-6.1 Sol with NVIDIA GPUs (NASDAQ:NVDA) instead of Cerebras hardware. Cerebras sells itself on fast inference, so losing a marquee speed workload strikes at the core of its thesis. Shares are down 52.87% from the $311.07 first-day close. That is well past the 30% mark that separates a pullback from a collapse, and it leaves the stock below its $185 IPO price.

Supply made matters worse. Up to 19.4 million shares held by insiders and employees unlocked, equal to 8% of total shares outstanding. CEO Andrew Feldman and CTO Sean Lie sold over $240 million of Class A shares under trading plans. The stock fell 19.24% over the past week, with 10.69% of that decline coming in the latest session.

The August earnings report had already shaken confidence. GAAP revenue of $180.11M missed the $193.55M consensus. GAAP EPS of -$2.98 missed the -$0.1801 estimate, largely because of $377M in stock-based compensation.

**UBS Holds a Street-High $330 Target as Estimates Keep Rising**

Timothy Arcuri at UBS holds the top target, rating the stock Buy with a $330.00 price target, implying about 125.1% upside. His thesis has three parts. First, disaggregated inference is gaining momentum as spending shifts from training to live inference. Second, capacity expansion provides multi-year revenue visibility. Third, he treats gross margin swings tied to short-term infrastructure rental reallocation costs as an accumulation window.

The company's own numbers support parts of that view. Core revenue rose 103% to $209.87M, and full-year core revenue guidance was raised to $880–$890M. Management called Q3 the low point for core gross margin and targets 60%-plus over the long term. Feldman said Cerebras is "preparing for a massive 2027, 2028, and 2029 as we deliver on the $25 billion of RPO we currently have on our books." Two near-term catalysts stand out: the AMD (NASDAQ:AMD) Helios disaggregated solution, expected to be deployed in Q4, and AWS Bedrock availability in Q1 2027.

Analysts are bullish:

- Strong Buy: 3

- Buy: 7

- Hold: 1

- Sell: 0

The 2027 EPS estimate has risen to $1.2737 from $0.9613 60 days ago, with 9 upward revisions and no cuts in 30 days. Read that skeptically. The average has stayed flat since before the OpenAI report, which suggests estimates have yet to account for it.

**Cerebras Fell Alone While the Chip Giants Held Their Gains**

Its peers did not sell off with it. NVIDIA slipped 5.27% over the past week but is up 21.64% year to date. At $226.32 against a $328.72 target, it offers 45.2% potential upside, with analyst ratings of 10 Strong Buy, 49 Buy, 2 Hold and 1 Sell. The upside is smaller than Cerebras', but it rests on a proven earnings base.

AMD fell 5.94% on the week and is still up 177.47% year to date. At $594.24 against a $636.21 target, it offers just 7.1% upside, with 5 Strong Buy, 39 Buy and 11 Hold ratings.

Cerebras carries the largest analyst-implied upside among these stocks by a wide margin, and it also has the weakest stock. That combination points to a company-specific problem rather than a sector-wide one.

**A 98.9% Target Gap While the S&P 500 Gains 14.1%**

At $146.62, Cerebras would need to gain about 98.9% to reach the $291.64 consensus from 11 analysts. Shares are down 23.61% over the past month. Over the same period, the S&P 500 gained 1.81% and is up 14.1% year to date.

The stock still trades at a forward P/E of 217, so even after the drop it is far from cheap. Treat price targets as one data point, subject to change.

**Backlog Justifies the Risk, but OpenAI Sets the Leash**

The bull case strengthens if the AMD and AWS disaggregated products ship on schedule and the expected Q4 margin rebound materializes, which would show that speed still wins workloads. The risk is that OpenAI's move to NVIDIA spreads to other workloads, since customer concentration in OpenAI, G42, MBZUAI and AWS leaves the backlog exposed.

With $6.74B in cash, near-term funding looks secure. The outlook is cautiously bullish. Still, the next earnings report needs to show where OpenAI revenue is headed before the UBS target looks reachable.